| Drug Name | GPCR-targeted Project 014 |
| Description |
The glucagon receptor (GCGR) is a 62 kDa peptide activated by glucagon and is a member of the G-protein coupled family of receptors. Stimulation of the receptor results in activation of adenylate cyclase and increased levels of intracellular cAMP. |
| Target | Glucagon receptor (GCGR) |
| Drug Modality | Monoclonal antibody |
| Indication | Diabetes; Hyperglycemia |
| Product Category | Biologic |
| Mechanism of Action | Glucagon receptor antagonists |
| Status | Preclinical |
| Patent | Granted |
We look forward to hearing from you.
Protheragen's business is growing rapidly after founded in Ronkonkoma, New York. Our business has evolved from the initial intermediary service to encompass segments in equity investment and program incubation.
 |
Protheragen Inc. |
 |
Quick Links |